Table 3 Univariate analysis of pathological characteristics of pelvic mass after hysterectomy with or without simultaneous bilateral salpingectomy
From: Effects of hysterectomy with simultaneous bilateral salpingectomy on the subsequent pelvic mass
Hys N(%) | Hys + BS N(%) | P value | |
|---|---|---|---|
Total number of cases | 198 | 14 | |
Malignant | |||
No | 135 (68.2) | 8 (57.1) | 0.391 |
Yes | 63 (31.8) | 6 (42.9) | |
Ovarian serous carcinoma | |||
0 | 175 (88.4) | 11 (78.57) | 0.388 |
1 | 23 (11.6) | 3 (21.43) | |
Ovarian mucous carcinoma | |||
0 | 190 (96.0) | 14 (100) | 1.0 |
1 | 8 (4.0) | 0 (0) | |
Ovarian endometrioid carcinoma | |||
0 | 194 (98.0) | 14 (100) | 1.0 |
1 | 4 (2.0) | 0 (0) | |
Ovarian clear cell carcinoma | |||
0 | 195 (98.5) | 13 (92.9) | 0.241 |
1 | 3 (1.5) | 1 (7.1) | |
Ovarian sarcoma | |||
0 | 196 (99.0) | 13 (92.9) | 0.186 |
1 | 2 (1.0) | 1 (7.1) | |
Ovarian undifferentiated carcinoma | |||
0 | 196 (99.0) | 14 (100) | 1.0 |
1 | 2 (1.0) | 0 (0) | |
Ovarian primary PNET | |||
0 | 198 (100) | 14 (100) | 1.0 |
1 | 0 (0) | 0 (0) | |
Other uncertain types of ovarian carcinoma | |||
0 | 192 (96.97) | 14 (100) | 1.0 |
1 | 6 (3.0) | 0 (0) | |
Pelvic extraovarian carcinoma | |||
0 | 190 (96) | 13 (92.9) | 0.466 |
1 | 8 (4) | 1 (7.1) | |
Peritoneal derived carcinoma | |||
0 | 195 (98.5) | 14 (100) | 1.0 |
1 | 3 (1.5) | 0 (0) | |
Vaginal stump carcinoma | |||
0 | 197 (99.5) | 14 (100) | 1.0 |
1 | 1 (0.5) | 0 (0) | |
Carcinoma in other sites | |||
0 | 195 (98.5) | 14 (100) | 1.0 |
1 | 3 (1.5) | 0 (0) | |
Benign | |||
No | 63 (31.8) | 6 (42.9) | 0.391 |
Yes | 135 (68.2) | 8 (57.1) | |
Cervical leiomyoma | |||
0 | 194 (98.0) | 14 (100) | 1.0 |
1 | 4 (2.0) | 0 (0) | |
Cervical intraepithelial neoplasia | |||
0 | 197 (99.5) | 14 (100) | 1.0 |
1 | 1 (0.5) | 0 (0) | |
Hydrosalpinx | |||
0 | 178 (89.9) | 14 (100) | 0.371 |
1 | 20 (10.0) | 0 (0) | |
Mesenchymal cyst of oviduct | |||
0 | 191 (93.9) | 14 (100) | 1.0 |
1 | 7 (6.1) | 0 (0) | |
Ovarian oviduct abscess | |||
0 | 196 (99.0) | 14 (100) | 1.0 |
1 | 2 (1.0) | 0 (0) | |
Ovarian endometriosis | |||
0 | 168 (84.8) | 12 (85.7) | 1.0 |
1 | 30 (15.2) | 2 (14.3) | |
Ovarian physiological cysts | |||
0 | 178 (89.9) | 14 (100) | 1.0 |
1 | 20 (10.1) | 0 (0) | |
Ovarian serous cystadenoma | |||
0 | 184 (92.9) | 13 (92.8) | 1.0 |
1 | 14 (7.1) | 1 (7.2) | |
Ovarian mucinous cystadenoma | |||
0 | 178 (89.9) | 14 (100) | 0.370 |
1 | 20 (10.1) | 0 (0) | |
Ovarian fibroma | |||
0 | 194 (98.0) | 14 (100) | 1.0 |
1 | 4 (2.0) | 0 (0) | |
Ovarian teratoma | |||
0 | 195 (98.5) | 14 (100) | 1.0 |
1 | 3 (1.5) | 0 (0) | |
Ovarian epidermoid cyst | |||
0 | 196 (99.0) | 14 (100) | 1.0 |
1 | 2 (1.0) | 0 (0) | |
Encapsulated effusion | |||
0 | 184 (92.9) | 10 (71.4) | 0.021 |
1 | 14 (7.1) | 4 (28.6) | |
Intravascular leiomyomatosis | |||
0 | 196 (99.0) | 13 (92.9) | 0.186 |
1 | 2 (1.0) | 1 (7.1) | |
Pelvic leiomyoma | |||
0 | 196 (99.0) | 14 (100) | 1.0 |
1 | 2 (1.0) | 0 (0) | |
Others benign masses arising from extraovarian sites | |||
0 | 192 (97.0) | 14 (100) | 1.0 |
1 | 6 (3.0) | 0 (0) | |